Spotlight on atrial fibrillation - The 'complete arrhythmia'

Cardiovascular Research

Volumn 54, Issue 2, 2002, Pages 197-203

  Nattel, Stanley ^a   Allessie, Maurits ^b   Haissaguerre, Michel ^c  

^a MONTREAL HEART INSTITUTE   (Canada)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c UNIVERSITÉ DE BORDEAUX   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ION; CALPAIN; COLLAGEN; GAP JUNCTION PROTEIN; HYDROGEN; NERVE CELL ADHESION MOLECULE; POTASSIUM ION; TRANSFORMING GROWTH FACTOR BETA;

EDITORIAL; HEART ARRHYTHMIA; HEART ATRIUM; HEART ATRIUM FIBRILLATION; HEART ELECTROPHYSIOLOGY; HEART VENTRICLE CONTRACTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PULMONARY VEIN; SUPRAVENTRICULAR TACHYCARDIA; TACHYCARDIA;

ATRIAL FIBRILLATION; ATRIAL FUNCTION; CATHETER ABLATION; HEART CONDUCTION SYSTEM; HUMANS; RESEARCH DESIGN;

EID: 0036216486     PISSN: 00086363     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0008-6363(02)00324-3     Document Type: Editorial

References (64)

1. ABC of atrial fibrillation. History, epidemiology, and importance of atrial fibrillation
2. Ueber arythmische herzthätigkeit
3. Einige neue versuche über herzbewegung
4. Note sur les effets de la faradisation directe des ventricules du coeur chez le chien
5. On the interpretation of pulse-tracings
6. Rythme affolé des ventricules dûà la fibrillation des oreillettes: Physiologie du faisceau auriculo-ventriculaire
7. Auricular fibrillation and its relationship to clinical irregularity of the heart
8. Auricular fibrillation
9. A computer model of atrial fibrillation
10. Pathophysiology and prevention of atrial fibrillation
11. Prevalence, age distribution, and gender of patients with atrial fibrillation. Analysis and implications
12. Atrial fibrillation and stroke: Concepts and controversies
13. Impact of atrial fibrillation on the risk of death: The Framingham Heart Study
14. Prognostic significance of atrial fibrillation in advanced heart failure. A study of 390 patients
15. Mother rotors and fibrillatory conduction: A mechanism of atrial fibrillation
16. Mechanisms of atrial flutter and atrial fibrillation - Distinct entities or two sides of a coin?
17. Electrical, contractile and structural remodeling during atrial fibrillation. Facts and possible implications
18. Atrial fibrillation begets atrial fibrillation. A study in awake chronically instrumented goats
19. Signal transduction systems and atrial fibrillation
20. Cellular electrophysiology of atrial fibrillation
21. Cardiac gap junction and connexins: Their role in atrial fibrillation and potential as therapeutic targets
22. Radiofrequency catheter ablation of the atria eliminates pacing-induced sustained atrial fibrillation and reduces connexin43 in dogs
23. Altered pattern of connexin40 distribution in persistent atrial fibrillation in the goat
24. Gap junctional remodeling in relation to stabilization of atrial fibrillation in the goat
25. The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation
26. Effects of chronic atrial fibrillation on gap junction distribution in human and rat atria
27. Transgenic and knockout mouse models of atrial arrhythmias
28. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins
29. Basic and clinical electrophysiology of pulmonary vein ectopy
30. Thoracic veins and the mechanisms of non-paroxysmal atrial fibrillation
31. Electrophysiological properties of the human atrium in atrial fibrillation
32. Molecular mechanisms of remodeling in human atrial fibrillation
33. Atrial structure and fibres: Morphologic bases of atrial conduction
34. Ablation therapy for atrial fibrillation. Past present and future
35. Therapeutic implications of atrial fibrillation mechanisms: Can mechanistic insights be used to improve AF management?
36. Structural correlate of atrial fibrillation in human patients
37. Promotion of atrial fibrillation by heart failure in dogs: Atrial remodeling of a different sort
38. Activation of proteolysis by calpains and structural changes in human paroxysmal and persistant fibrillation
39. Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery
40. Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation
41. Molecular basis of downregulation of G-protein-coupled inward rectifying K(+) current I(K,ACh) in chronic human atrial fibrillation: Decrease in GIRK4 mRNA correlates with reduced I(KACh) and muscarinic receptor-mediated shortening of action potentials
42. Density and function of inward currents in rights atrial cells from chronically fibrillating canine atria
43. Tachycardia-induced changes in sodium current in a chronic dog model of atrial fibrillation
44. Ionic mechanisms of electrical remodeling in human atrial fibrillation
45. 2+ handling by atrial tachycardia-evidence for a role in loss of rate-adaptation
46. Failure in the rate adaptation of the atrial refractory period: Its relationship to vulnerability
47. Mathematical analysis of canine atrial action potentials: Rate, regional factors and electrical remodeling
48. The cellular mechanisms of atrial contractile dysfunction caused by sustained atrial tachycardia
49. Analysis of altered gene expression during sustained atrial fibrillation in the goat
50. +/H+-exchange or angiotensin converting enzyme on atrial tachycardia-induced remodeling
51. + exchanger in short-term atrial electrophysiological remodeling
52. Angiotensin II antagonist prevents electrical remodeling in atrial fibrillation
53. Daily oral verapamil before but not after rapid atrial excitation prevents electrical remodeling
54. Pretreatment with verapamil in patients with persistent or chronic atrial fibrillation who underwent electrical cardioversion
55. VERDICT: The Verapamil versus Digoxin Cardioversion Trial: A randomized study on the role of calcium lowering for maintenance of sinus rhythm after cardioversion of persistent atrial fibrillation
56. Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs
57. Enalapril effects on atrial remodeling and atrial fibrillation in experimental congestive heart failure
58. Effects of angiotensin-converting enzyme inhibition on the development of the atrial fibrillation substrate in dogs with ventricular tachypacing-induced congestive heart failure
59. Cellular electrophysiologic properties of old canine atria provide a substrate for arrhythmogenesis
60. Endovascular stimulation within the left pulmonary artery to induce slowing of heart rate and paroxysmal atrial fibrillation
61. The atrial arrhythmia syndrome of vagal origin
62. Suppression of atrial fibrillation by multisite and septal pacing in a novel experimental model
63. Multisite pacing for prevention of atrial tachyarrhythmias: Potential mechanisms